Ontology highlight
ABSTRACT: Background
Irritable bowel syndrome (IBS) is highly prevalent and presents a clinical challenge. Gelsectan is a medical device containing xyloglucan (XG), pea protein and tannins (PPT) from grape seed extract, and xylo-oligosaccharides (XOS), which act together to protect and reinforce the intestinal barrier.Objective
The objective of this study is to evaluate the efficacy and safety of XG + PPT + XOS in patients with diarrhoea-predominant IBS (IBS-D).Methods
In this double-blind study, 60 patients were randomly assigned to receive XG + PPT + XOS or placebo for 28 days, then crossed over to the alternative treatment. Patients were followed for 60 days.Results
At Day 28, a significantly higher proportion of patients starting treatment with XG + PPT + XOS than
SUBMITTER: Trifan A
PROVIDER: S-EPMC6794699 | biostudies-literature | 2019 Oct
REPOSITORIES: biostudies-literature